Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-29

Clinical Trial Update: Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT

View source ↗

Summary

A natural history study in inherited retinal diseases caused by mutations in RPE65 or LRAT has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: QLT Inc. | Conditions: Leber Congenital Amaurosis (LCA), Retinitis Pigmentosa (RP) | Status: COMPLETED